Quantitative Effects of Valacyclovir on the Replication of Cytomegalovirus (CMV) in Persons with Advanced Human Immunodeficiency Virus Disease: Baseline CMV Load Dictates Time to Disease and Survival

Autor:	AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group, Emery, V. C., Sabin, C., Feinberg, J. E., Grywacz, M., Knight, S., Griffiths, P. D.
Zdroj:	The Journal of Infectious Diseases, 1999 Sep 01. 180(3), 695-701.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/30111076 Zobrazit plný text záznamu